These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29328649)

  • 1. Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases.
    Schulz R; Atef A; Becker D; Gottschalk F; Tauber C; Wagner S; Arkona C; Abdel-Hafez AA; Farag HH; Rademann J; Wolber G
    J Med Chem; 2018 Feb; 61(3):1218-1230. PubMed ID: 29328649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-covalent inhibitors of rhinovirus 3C protease.
    Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
    Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.
    Huang L; Brinen LS; Ellman JA
    Bioorg Med Chem; 2003 Jan; 11(1):21-9. PubMed ID: 12467703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
    Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
    J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
    Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
    Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
    Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
    Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
    J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.
    Kathman SG; Xu Z; Statsyuk AV
    J Med Chem; 2014 Jun; 57(11):4969-74. PubMed ID: 24870364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Iminooxazolidin-2-one as a Bioisostere of the Cyanohydrin Moiety: Inhibitors of Enterovirus 71 3C Protease.
    Ma Y; Shang C; Yang P; Li L; Zhai Y; Yin Z; Wang B; Shang L
    J Med Chem; 2018 Nov; 61(22):10333-10339. PubMed ID: 30365311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches.
    Katritch V; Byrd CM; Tseitin V; Dai D; Raush E; Totrov M; Abagyan R; Jordan R; Hruby DE
    J Comput Aided Mol Des; 2007; 21(10-11):549-58. PubMed ID: 17960327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new class of nonpeptidic inhibitors of cruzain.
    Brak K; Doyle PS; McKerrow JH; Ellman JA
    J Am Chem Soc; 2008 May; 130(20):6404-10. PubMed ID: 18435536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors.
    Yin J; Cherney MM; Bergmann EM; Zhang J; Huitema C; Pettersson H; Eltis LD; Vederas JC; James MN
    J Mol Biol; 2006 Aug; 361(4):673-86. PubMed ID: 16860823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-wise design of inhibitors to 3C proteinase from enterovirus 71.
    Wu C; Zhang L; Li P; Cai Q; Peng X; Yin K; Chen X; Ren H; Zhong S; Weng Y; Guan Y; Chen S; Wu J; Li J; Lin T
    Biochim Biophys Acta; 2016 Jun; 1860(6):1299-307. PubMed ID: 26987809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses.
    Meng B; Lan K; Xie J; Lerner RA; Wilson IA; Yang B
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13499-13508. PubMed ID: 32467165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-quantitative structure-activity relationship study for the design of novel enterovirus A71 3C protease inhibitors.
    Nie Q; Xu X; Zhang Q; Ma Y; Yin Z; Shang L
    Chem Biol Drug Des; 2018 Oct; 92(4):1750-1762. PubMed ID: 29877617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors.
    Dragovich PS; Zhou R; Webber SE; Prins TJ; Kwok AK; Okano K; Fuhrman SA; Zalman LS; Maldonado FC; Brown EL; Meador JW; Patick AK; Ford CE; Brothers MA; Binford SL; Matthews DA; Ferre RA; Worland ST
    Bioorg Med Chem Lett; 2000 Jan; 10(1):45-8. PubMed ID: 10636240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitors.
    Schünemann K; Connelly S; Kowalczyk R; Sperry J; Wilson IA; Fraser JD; Brimble MA
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5018-24. PubMed ID: 22763202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
    Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
    Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-guided screening of fragments (TGSOF) in the discovery of inhibitors against EV-A71 3C protease.
    Fu S; Nie Q; Ma Y; Song P; Ren X; Luo C; Shang L; Yin Z
    Chem Commun (Camb); 2018 Mar; 54(23):2890-2893. PubMed ID: 29497732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents.
    Karypidou K; Ribone SR; Quevedo MA; Persoons L; Pannecouque C; Helsen C; Claessens F; Dehaen W
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3472-3476. PubMed ID: 30286952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.